Trials / Completed
CompletedNCT00776347
Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Osaka University · Academic / Other
- Sex
- All
- Age
- 60 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate change of cerebral glucose metabolism by donepezil therapy and to associate change of glucose metabolism and symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Donepezil | Dosage: 3mg PO/day for the first 2 weeks and 5mg PO/day for the next 14 weeks Duration: 16 weeks |
| DRUG | Donepezil |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2008-10-21
- Last updated
- 2015-10-15
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00776347. Inclusion in this directory is not an endorsement.